Anticancer Effect of Doenjang in in vitro Sulforhodamine B (SRB) Assay

된장의 in vitro Sulforhodamine B (SRB) Assay에 의한 암세포 증식 억제 효과

  • 이숙희 (부산대학교 식품영양학과) ;
  • 임선영 (부산대학교 식품영양학과) ;
  • 박건영 (부산대학교 식품영양학과)
  • Published : 1999.02.01

Abstract

Growth inhibitory effect of doenjang(Korean soypaste) methanol extracts in SRB assay using AGS human gastric adenocarcinoma cell, Hep 3B human hepatocellular carcinoma cell and HT 29 human colon cancer cell was studied. The treatment of doenjang methanol extracts(2mg/assay) to the AGS, Hep 3B and HT 29 cancer cells inhibited the growth of the cancer cells by 55%, 60%, and 71%, respectively. Doenjang methanol extracts exhibited the highest inhibitory effect among other soybean fermented foods and original materials in the SRB assay. In addition, to separate active compounds of doenjang methanol extracts, we fractionated the doenjang with hexane, methanol, dichloromethane, ethylacetate and butanol. Growth inhibitory effect on the AGS, Hep 3B, HT 29 and MG 63 cancer cells was the highest in the fractions of dichloromethane and ethylacetate among other solvent fractions of the doenjang. These results showed that some compounds contained in the fractions of dichloromethane and ethylacetate might play a role on the anticanceric effect of doenjang.

Keywords

References

  1. 한국의 발효식품 이서래
  2. J. Kor. Agrcic. Chem. Soc. v.29 The Characteristics of bacteria isolated from ofdinary Korean soy sauce and soybean paste Kwon, O. J.;Kim, J. K.;Chung, Y. G.
  3. Omega-3 fatty acids in health and disease Effects of omega-3 fatty acids on risk factors for cardiovascular diseas Illingworth, D. R.;Ullmann, D.;Lees, R. S.;Karel, M.(eds.)
  4. Am. J. Clin. Nutr. v.51 Reduced arachidonate in serum phoshpholipids and cholesteryl esters associated with vegetarian diets in humans Phinney, S. D.;Odin, R. S.;Johnson, S. B.;Holman, R. T.
  5. Eur. J. Clin. Invest. v.25 n-3 polyunsaturated fatty acids : update 1995 Endres, S.;De Caterina, R.;Schmidt, E. B.;Kristensen, S. D.
  6. J. Food Prot. v.51 Aflatoxin production by Aspergillus parasiticus and its stability during the manufacture of Korean soy paste(Doenjang) and soy sauce(Kanjang) by traditional method Park, K. Y.;Lee, K. B.;Bullerman, L. B.
  7. J. Colle. Home Eco. v.13 Degradation of aflatoxin during the manufacture of doenjang and Kanjang by traditional method Park, K. Y.;Lee, K. B.
  8. J. Korean Soc. Food. Nutr. v.18 Effect of ammonia and pH on the degradation of aflatoxin B₁during the storage of Korean soy sauce(kanjang) Park, K. Y. K. Y.;Lee, E. S.
  9. J. Nutr. v.125 The eidence for soybean products as cancer preventive agents Kennedy, A. R.
  10. Cancer Res. v.41 Effects of protease inhibitors on radiation transformation in vitro Kennedy, A. R.;Little, J. B.
  11. Cancer Res. v.39 Inhibition of chemical transformation in C3H/10T1/2 cells by protease inhibitors Kuroki, T.;Drevon, C.
  12. J. Nutr. v.125 Soybean phytoestrogen intake and cancer risk Adlercreutz, C. H. T.;Goldin, B. R.;Gorbach, S. L.;Watanabe, S.;Hahala, K. T.;Hase, T. A.;Fotsis, T.
  13. Anticancer Res. v.15 Structural requirements for differention-induction and growth-inhibition of mouse erythroleukemia cells by isoflabones Jing, Y.;Waxman, S.
  14. J. Nutr. v.125 Inositol phosphates have novel anti-cancer function Shamsuddin, A. M.
  15. J. Nutr. v.125 Saponins as anticarcinogens Rao, A. V.;Sung, M. K.
  16. Diet and Nutrition v.14 Lignans and phytoestrogens. :ossible preventive role in cancer Adlercreutz, H.
  17. Carcinogenesis v.11 Inhibition of experimental colorectal carcinogenesis by dietary N-6-polyunsaturated fats Nicholson, M. L.;Neoptolemos, J. P.;Clayton, H. A.;Talbot, I. C.;Bell, P. R. F.
  18. Korean J. Life Science v.5 Inhibitory effect of linolinic acid on the mutagens-induced mutagenicities in Ames assay system and SOS chormotest Lim, S. Y.;Rhee, S. H.;Park, K. Y.
  19. Environ. Mut. Carcino. v.14 Antimutagenic effect of doenjong(Korean soy paste)-Inhibitory effect of doenjang stew and soup on the mutagenicity induced by aflatoxin B₁ Park, K. Y. Moon, S. H.;Rhee, S. H.
  20. Cancer Res. v.48 Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay Alley, M. C.;Scudiero, D. A.;Monks, A.;Hursey, M. L.;Czerwinski, M. J.;Fine, D. L.;Abbott, B. J.;Mayo, J. G.;Shoemaker, R. H.;Boyd, M. R.
  21. Cancer Res. v.48 Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in cylture using human and other tumor cell lines Scudiere, D. A.;Shoemaker, R.;Paull, K.;Monks, a.;Tierney, S.;Nofziger, T. H.;Currens, M. J.;Seniff, D.;Boyd, M. R.
  22. Cancer Treat. Rep. v.67 The national cancer institute antitumor drug discovery program, current and future perspectives : a commentary Venditti, J. M.
  23. J. Immunol. Meth. v.65 Rapid colormetric assay for cellular growth and survival : Application to proliferation and cytotoxicity assay Mosman, t.
  24. J. Natl. Cancer Inst. v.83 Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines Monks, a.;Scudiero, D.;Skehan, P.;Shoemaker, R.;Paull, K.;Vistica, D.;Hose, C.;Langley, J.;Cronise, P.;Vaigro-Wolff, a.;Gray-Goodrich, M.;Campbell, H.;Mayo, J.;Boyr, M.